Shares of CIGNA Co. (NYSE:CI) reached a new 52-week high during trading on Tuesday . The company traded as high as $178.68 and last traded at $178.61, with a volume of 586,231 shares traded. The stock had previously closed at $176.35.

A number of analysts recently commented on CI shares. Deutsche Bank AG lifted their price objective on CIGNA from $180.00 to $190.00 and gave the stock a “buy” rating in a research report on Monday, August 7th. Morgan Stanley lifted their price objective on CIGNA from $184.00 to $188.00 and gave the stock an “overweight” rating in a research report on Monday, August 7th. CIBC lifted their price objective on CIGNA from $174.00 to $185.00 and gave the stock an “outperform” rating in a research report on Thursday, June 15th. Wells Fargo & Company reiterated a “market perform” rating and set a $174.00 price objective (up previously from $163.00) on shares of CIGNA in a research report on Monday, June 19th. Finally, Oppenheimer Holdings, Inc. lifted their price objective on CIGNA from $174.00 to $185.00 and gave the stock an “outperform” rating in a research report on Thursday, June 15th. Three research analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company’s stock. CIGNA has an average rating of “Buy” and a consensus target price of $180.06.

The stock has a market capitalization of $44.95 billion, a price-to-earnings ratio of 20.60 and a beta of 0.46. The stock has a 50 day moving average price of $172.41 and a 200 day moving average price of $159.55.

CIGNA (NYSE:CI) last issued its earnings results on Friday, August 4th. The health services provider reported $2.91 earnings per share for the quarter, topping the consensus estimate of $2.48 by $0.43. CIGNA had a return on equity of 22.67% and a net margin of 7.85%. The company had revenue of $10.32 billion for the quarter, compared to analyst estimates of $10.26 billion. During the same period in the prior year, the firm posted $1.98 EPS. The business’s revenue was up 3.6% compared to the same quarter last year. On average, equities analysts expect that CIGNA Co. will post $10.03 earnings per share for the current fiscal year.

In other news, CEO David Cordani sold 153,168 shares of the stock in a transaction dated Monday, June 19th. The stock was sold at an average price of $170.20, for a total transaction of $26,069,193.60. Following the transaction, the chief executive officer now owns 421,162 shares of the company’s stock, valued at approximately $71,681,772.40. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, VP Mary T. Hoeltzel sold 525 shares of the stock in a transaction dated Wednesday, August 9th. The shares were sold at an average price of $177.59, for a total value of $93,234.75. Following the transaction, the vice president now directly owns 1,924 shares in the company, valued at approximately $341,683.16. The disclosure for this sale can be found here. In the last three months, insiders have sold 261,539 shares of company stock worth $44,527,348. 1.30% of the stock is currently owned by insiders.

Several hedge funds and other institutional investors have recently modified their holdings of CI. BlackRock Inc. raised its position in shares of CIGNA by 2,335.5% in the first quarter. BlackRock Inc. now owns 16,987,425 shares of the health services provider’s stock worth $2,488,489,000 after buying an additional 16,289,943 shares in the last quarter. JPMorgan Chase & Co. raised its position in shares of CIGNA by 40.8% in the second quarter. JPMorgan Chase & Co. now owns 4,088,728 shares of the health services provider’s stock worth $684,413,000 after buying an additional 1,184,632 shares in the last quarter. Waddell & Reed Financial Inc. raised its position in shares of CIGNA by 125.8% in the first quarter. Waddell & Reed Financial Inc. now owns 1,749,647 shares of the health services provider’s stock worth $256,306,000 after buying an additional 974,747 shares in the last quarter. Wellington Management Group LLP raised its position in shares of CIGNA by 9.3% in the first quarter. Wellington Management Group LLP now owns 10,765,751 shares of the health services provider’s stock worth $1,577,075,000 after buying an additional 913,991 shares in the last quarter. Finally, Thrivent Financial For Lutherans raised its position in shares of CIGNA by 7,868.4% in the first quarter. Thrivent Financial For Lutherans now owns 708,390 shares of the health services provider’s stock worth $103,772,000 after buying an additional 699,500 shares in the last quarter. 87.61% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: This news story was originally published by Daily Political and is owned by of Daily Political. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at https://www.dailypolitical.com/2017/08/15/cigna-co-ci-sets-new-12-month-high-at-178-68.html.

About CIGNA

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Receive News & Ratings for CIGNA Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA Co. and related companies with MarketBeat.com's FREE daily email newsletter.